The exposure for CYC was way different also - they were entering a market worth 'only' $280m, against a lot of competition and some would argue there are better devices. In BOT's case it is PROVEN to be the superior, self-applied, PAH medication available to patients.
Bot Chart, page-12092
-
- There are more pages in this discussion • 2,890 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.8¢ |
Change
-0.003(0.68%) |
Mkt cap ! $662.1M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.5¢ | $336.5K | 910.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 197432 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 191001 | 10 |
View Market Depth
| Last trade - 10.58am 07/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |